{
    "response": "**Overall Treatment Decision:** Yes\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** Intravenous Methylprednisolone\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** To accelerate recovery of visual function in acute/subacute optic neuritis Significant visual acuity deficit (6/36) warrants aggressive management\n\n*   **Treatment:** Gastroprotection (e.g., Omeprazole)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Prophylaxis against gastritis/ulceration during high-dose steroid therapy\n\n*   **Treatment:** Disease Modifying Therapy (e.g., Ocrelizumab, Natalizumab)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Requires confirmation of specific diagnosis (MS vs NMOSD) Requires results of infectious screening and baseline bloods prior to initiation\n\n\ntreatments = [{\"treatment\": \"Intravenous Methylprednisolone\", \"timing\": \"Start Now\", \"reasons\": [\"To accelerate recovery of visual function in acute/subacute optic neuritis\", \"Significant visual acuity deficit (6/36) warrants aggressive management\"]}, {\"treatment\": \"Gastroprotection (e.g., Omeprazole)\", \"timing\": \"Start Now\", \"reasons\": [\"Prophylaxis against gastritis/ulceration during high-dose steroid therapy\"]}, {\"treatment\": \"Disease Modifying Therapy (e.g., Ocrelizumab, Natalizumab)\", \"timing\": \"Delay\", \"reasons\": [\"Requires confirmation of specific diagnosis (MS vs NMOSD)\", \"Requires results of infectious screening and baseline bloods prior to initiation\"]}]"
}